GEMMA Biotherapeutics
May Orfali, MD, currently serves as the Chief Medical Officer at GEMMA Biotherapeutics and Harbinger Health. In addition to these roles, May Orfali is the Owner and Principal Consultant at Rare Disease and Oncology Consulting, LLC. With extensive experience in medical leadership and consulting, May Orfali specializes in advancing therapeutic strategies in the fields of rare diseases and oncology.
This person is not in any teams
This person is not in any offices
GEMMA Biotherapeutics
GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases. Alongside Franklin Biolabs, GEMMABio will advance gene therapy research and deliver therapeutics to patients around the world significantly faster.